1. Home
  2. BOC vs PEPG Comparison

BOC vs PEPG Comparison

Compare BOC & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Omaha Corporation

BOC

Boston Omaha Corporation

HOLD

Current Price

$12.84

Market Cap

387.8M

Sector

N/A

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.54

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOC
PEPG
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
387.8M
440.0M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
BOC
PEPG
Price
$12.84
$5.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$25.00
$11.67
AVG Volume (30 Days)
105.5K
606.2K
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
82.61
25.61
EPS
N/A
N/A
Revenue
$108,274,901.00
N/A
Revenue This Year
$6.06
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.49
N/A
52 Week Low
$11.30
$0.89
52 Week High
$15.72
$7.80

Technical Indicators

Market Signals
Indicator
BOC
PEPG
Relative Strength Index (RSI) 60.13 44.57
Support Level $12.09 $4.36
Resistance Level $12.99 $6.81
Average True Range (ATR) 0.28 0.58
MACD 0.08 -0.03
Stochastic Oscillator 75.93 26.49

Price Performance

Historical Comparison
BOC
PEPG

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: